Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|March 14, 2022
A Paradoxical Effect of Interleukin-32 Isoforms on CancerSaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology|March 14, 2022
Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological ActivitySaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Arthritis Research & Therapy|December 5, 2015
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiationEun-Ju Lee, Eun-Jin Lee, Yeon-Ho Chung, et al.
Chest|January 10, 2021
Case of a 21-Year-Old Man With Hemoptysis, Recurrent Pneumothorax, and Cavitary Lung LesionsSang Yong Park, Ho Cheol Kim, Seongbong Wee, et al.
Rheumatology (Oxford, England)|August 2, 2012
Elevated interleukin-32 expression in granulomatosis with polyangiitisSuyoung Bae, Yong-Gil Kim, Jida Choi, et al.
The European Respiratory Journal|August 9, 2014
Mycobacterial diseases developed during anti-tumour necrosis factor-α therapyJung-Wan Yoo, Kyung-Wook Jo, Bo-Hyung Kang, et al.
Arthritis Research & Therapy|July 31, 2024
Expression of CD163 and major histocompatibility complex class I as diagnostic markers for idiopathic inflammatory myopathiesByeongzu Ghang, So Hye Nam, Wonho Choi, et al.
International Journal of Rheumatic Diseases|July 12, 2021
Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) dataHyemin Jeong, Yong-Gil Kim, Tae-Hwan Kim, et al.
Scientific Reports|January 13, 2017
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of OsteoporosisEun-Jin Lee, Sang-Min Kim, Bongkun Choi, et al.
Psychopharmacology|April 20, 2011
The use of healthy volunteers instead of patients to inform drug dosing studies: a [¹¹C]raclopride PET studyEuitae Kim, Oliver D Howes, Bo-Hyung Kim, et al.
Pageof 21